Antares Pharma reported $29.76M in Gross Profit on Sales for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abbott ABT:US $ 6908M 160M
Abbvie ABBV:US $ 9517M 1089M
Adma Biologics ADMA:US $ 3.66M 3.28M
Aerie Pharmaceuticals AERI:US $ 108.6M 87.18M
Ani Pharmaceuticals ANIP:US $ 30.21M 3.18M
Atrion ATRI:US 17.38M 414K
Becton, Dickinson and BDX:US $ 2305M 118M
Cerus CERS:US $ 24.94M 5.67M
Eli Lilly And LLY:US $ 5737.9M 211.8M
Endo International Ordinary Shares ENDP:US $ 472.5M 2.65M
Horizon Pharma HZNP:US $ 670.18M 102.77M
JAZZ PHA JAZZ:US $ 698.44M 62.14M
Meridian Bioscience VIVO:US $ 68.48M 19.32M
Orasure Technologies OSUR:US $ 24.27M 2.86M
Pacira Pharmaceuticals PCRX:US $ 121.92M 1.73M
Pfizer PFE:US $ 15651M 1516M
Revance Therapeutics RVNC:US $ 17.37M 701K
Sientra SIEN:US 12.84M 518K
Supernus Pharmaceuticals SUPN:US $ 142.06M 11.68M
Teva Pharmaceutical TEVA:IT 2.12B 227M
Teva Pharmaceutical Industries TEVA:US $ 1802M 323M